EX-99 2 tm2025841d1_ex99.htm EXHIBIT 99

 

Exhibit 99

 

 

 

 

Silicon Labs Announces Second Quarter 2020 Results

 

-- Strong Results Led by Accelerating Trends in Connectivity --

 

AUSTIN, Texas – July 29, 2020 – Silicon Labs (NASDAQ: SLAB), a leading provider of silicon, software and solutions for a smarter, more connected world, today reported financial results for its second quarter ended July 4, 2020. Revenue was near the top end of the guidance range at $207.5 million, down from $214.9 million in the first quarter. Second quarter GAAP and non-GAAP diluted earnings (loss) per share (EPS) were $(0.04) and $0.74, respectively.

 

Second quarter revenue was at the high end of our guidance range at $207.5 million,” said Tyson Tuttle, CEO of Silicon Labs. “Clearly, the global pandemic has and will continue to impact the way people live, work and play. We are well-positioned to execute our strategy in IoT connectivity and internet infrastructure in light of recent trends in the market, which we see accelerating as the world moves even faster to becoming more connected.

 

Second Quarter Financial Highlights

 

·IoT revenue declined to $115.1 million, down 3% sequentially and 8% year-on-year.
·Infrastructure and Automotive revenue declined to $92.5 million, down 5% sequentially and up 13% year-on-year.

 

On a GAAP basis:

 

·GAAP gross margin was 60.9%.
·GAAP R&D expenses were $71 million.
·GAAP SG&A expenses were $48 million.
·GAAP operating income as a percentage of revenue was 3.4%.
·GAAP diluted loss per share was $(0.04).

 

On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, restructuring charges, non-cash interest expense and other costs associated with convertible notes, and certain other items as set forth in the reconciliation tables below:

 

·Non-GAAP gross margin was 61.4%.
·Non-GAAP R&D expenses were $52 million.
·Non-GAAP SG&A expenses were $37 million.
·Non-GAAP operating income as a percentage of revenue was 18.0%.
·Non-GAAP diluted earnings per share were $0.74.

 

 

 

 

Product Results

 

·Announced the EFP01 PMIC family, a new line of energy-friendly power management ICs serving as dedicated companion chips for EFR32 wireless devices and EFM32 microcontrollers. The EFP01 PMIC family provides a flexible, system-level power management solution enhancing the energy efficiency of battery-powered applications including IoT sensors, asset tags, smart meters, home and building automation, security, and health and wellness products.

 

Business Highlights

 

·Successfully completed the operational integration of Redpine Signals’ connectivity business and Hyderabad, India design center.
·Joined the Wi-SUN Alliance’s board of directors to accelerate the global adoption of Wi-SUN. The Wi-SUN Alliance aims to advance seamless, ubiquitous LPWAN connectivity via a standards-based, interoperable solution for global markets.
·Continued preparation for our first-ever Works With smart home developer conference September 9th – 10th, a two-day virtual event where smart home developers will learn how to connect our platforms, devices and protocols to work with ecosystems from industry leaders including Amazon, Apple HomeKit, Google, Samsung and many others.
·Migrated marketing and customer engagement initiatives to a virtual environment, holding weekly virtual Tech Talks and BG22 workshops with more attendees, repeat views and more accounts engaged than in-person events of this nature.
·Added Karuna Annavajjala to Silicon Labs’ executive team as Chief Information Officer to lead the company’s global IT team responsible for strategic planning, business application platforms, cyber security and service delivery.

 

Business Outlook

 

The company expects third quarter revenue to be in the range of $208 to $218 million, with IoT up and Infrastructure & Automotive down, and estimates the following:

 

On a GAAP basis:

 

·GAAP gross margin at approximately 60%.
·GAAP operating expenses at approximately $118 million.
·GAAP effective tax rate of 0.0%.
·GAAP diluted earnings (loss) per share between $(0.01) and $0.09.

 

On a non-GAAP basis, and excluding the impact of stock compensation, amortization of acquired intangible assets, acquisition related charges, restructuring charges, non-cash interest expense and other costs associated with convertible notes, and certain other items as set forth in the reconciliation tables below:

 

·Non-GAAP gross margin at approximately 60.5%.
·Non-GAAP operating expenses at approximately $92 million.
·Non-GAAP effective tax rate at 11.5%.
·Non-GAAP diluted earnings per share between $0.67 and $0.77.

 

 

 

 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available on Silicon Labs' website (www.silabs.com) under Investor Relations. A replay will be available after the call at the same website listed above or by calling 1 (877) 344-7529 (US) or (412) 317-0088 (International) and entering access code 10145993. The replay will be available through August 29, 2020.

 

About Silicon Labs

 

Silicon Labs (NASDAQ: SLAB) is a leading provider of silicon, software and solutions for a smarter, more connected world. Our award-winning technologies are shaping the future of the Internet of Things, Internet infrastructure, industrial automation, consumer and automotive markets. Our world-class engineering team creates products focused on performance, energy savings, connectivity and simplicity. silabs.com

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words "believe," "estimate," "expect," "intend," "anticipate," "plan," "project," "will" and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the impact of COVID-19 on the U.S. and global economy, including the restrictions on travel and transportation and other actions taken by governmental authorities and disruptions to the business of our customers or our global supply chain that have occurred or may occur in the future, the ongoing impact of COVID-19 on our employees and our ability to provide services to our customers and respond to their needs; risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

 

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: George Lane, +1 (512) 712-0019, George.Lane@silabs.com

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

 

   Three Months Ended   Six Months Ended 
   July 4,
2020
   June 29,
2019
   July 4,
2020
   June 29,
2019
 
Revenues  $207,533   $206,709   $422,410   $394,822 
Cost of revenues   81,222    79,660    166,933    151,899 
Gross profit   126,311    127,049    255,477    242,923 
Operating expenses:                    
Research and development   70,838    63,856    142,061    125,422 
Selling, general and administrative   48,404    48,637    102,400    97,853 
Operating expenses   119,242    112,493    244,461    223,275 
Operating income   7,069    14,556    11,016    19,648 
Other income (expense):                    
Interest income and other, net   3,267    3,696    6,518    6,519 
Interest expense   (11,778)   (5,005)   (17,319)   (10,002)
Income (loss) before income taxes   (1,442)   13,247    215    16,165 
Provision (benefit) for income taxes   381    29,276    (206)   26,796 
                     
Net income (loss)  $(1,823)  $(16,029)  $421   $(10,631)
                     
Earnings (loss) per share:                    
Basic  $(0.04)  $(0.37)  $0.01   $(0.25)
Diluted  $(0.04)  $(0.37)  $0.01   $(0.25)
                     
Weighted-average common shares outstanding:                    
Basic   43,761    43,386    43,699    43,287 
Diluted   43,761    43,386    44,219    43,287 

 

 

 

 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

Non-GAAP Income
Statement Items
 

Three Months Ended

July 4, 2020

 
  

GAAP

Measure

  

GAAP

Percent of Revenue

  

Stock

Compensation Expense

   Intangible Asset Amortization   Acquisition Related Items   Restructuring Charges  

Non-GAAP

Measure

  

Non-GAAP

Percent of Revenue

 
Revenues  $207,533                                    
                                         
Gross margin   126,311    60.9%  $376   $--   $608   $44   $127,339    61.4%
                                         
Research and development   70,838    34.1%   7,072    8,454    2,017    844    52,451    25.3%
                                         
Selling, general and administrative   48,404    23.4%   7,009    2,764    767    397    37,467    18.1%
                                         
Operating income   7,069    3.4%   14,457    11,218    3,392    1,285    37,421    18.0%

 

Non-GAAP

Earnings Per Share

 

Three Months Ended

July 4, 2020

 
  

GAAP

Measure

  

Stock

Compensation Expense*

   Intangible Asset Amortization*   Acquisition Related Items*   Restructuring Charges*  

Interest Expense

Adjustments*

  

Income

Tax

Adjustments

  

Non-

GAAP

Measure

 
Net income (loss)  $(1,823)  $14,457   $11,218   $3,392   $1,285   $8,692   $(4,533)  $32,688 

 

   GAAP
Measure
   Dilutive Securities Excluded From GAAP Measure Due to Net Loss  Non-
GAAP
Measure
 
Diluted shares outstanding   43,761   293    44,054 
                                                        
Diluted earnings (loss) per share  $(0.04)                                                   $0.74 

 

* Represents pre-tax amounts

 

Unaudited Forward-Looking Statements Regarding Business Outlook

(In millions, except per share data)

 

Business Outlook   Three Months Ending
October 3, 2020
 
      GAAP
Measure
      Non-GAAP
Adjustments*
      Non-GAAP
Measure
 
Gross margin     60 %     0.5 %     60.5 %
                         
Operating expenses   $ 118     $ 26     $ 92  
                         
Effective tax rate     0.0 %     11.5 %     11.5 %
                         
Diluted earnings (loss) per share - low   $ (0.01 )   $ 0.68     $ 0.67  
                         
Diluted earnings per share - high   $ 0.09     $ 0.68     $ 0.77  

 

* Non-GAAP adjustments include the following estimates: stock compensation expense of $14.9 million, intangible asset amortization of $11.8 million, acquisition related items of $1.2 million, restructuring charges of $0.04 million, and interest expense adjustments of $6.1 million, and associated tax impact from the aforementioned items. 

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

   July 4,
2020
   December 28,
2019
 
Assets          
Current assets:          
Cash and cash equivalents  $277,659   $227,146 
Short-term investments   445,685    498,825 
Accounts receivable, net   70,487    75,639 
Inventories   70,022    73,057 
Prepaid expenses and other current assets   53,584    69,192 
Total current assets   917,437    943,859 
Property and equipment, net   140,200    135,939 
Goodwill   631,932    398,402 
Other intangible assets, net   189,923    134,279 
Other assets, net   44,215    62,374 
Total assets  $1,923,707   $1,674,853 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $40,245   $38,899 
Deferred revenue and returns liability   26,358    19,251 
Other current liabilities   68,397    79,551 
Total current liabilities   135,000    137,701 
Convertible debt   571,774    368,257 
Other non-current liabilities   59,287    53,844 
Total liabilities   766,061    559,802 
Commitments and contingencies          
Stockholders' equity:          
Preferred stock – $0.0001 par value; 10,000 shares authorized; no
shares issued
   --    -- 
Common stock – $0.0001 par value; 250,000 shares authorized;
43,796 and 43,496 shares issued and outstanding at
July 4, 2020 and December 28, 2019, respectively
   4    4 
Additional paid-in capital   173,477    133,793 
Retained earnings   981,554    980,608 
Accumulated other comprehensive income   2,611    646 
Total stockholders' equity   1,157,646    1,115,051 
Total liabilities and stockholders' equity  $1,923,707   $1,674,853 

 

 

 

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   Six Months Ended 
   July 4,
2020
   June 29,
2019
 
Operating Activities          
Net income (loss)  $421   $(10,631)
Adjustments to reconcile net income (loss) to cash provided by operating activities:          
Depreciation of property and equipment   8,428    8,447 
Amortization of other intangible assets and other assets   21,568    20,476 
Amortization of debt discount and debt issuance costs   8,359    6,659 
Loss on extinguishment of convertible debt   3,685    -- 
Stock-based compensation expense   29,770    26,253 
Deferred income taxes   1,177    24,043 
Changes in operating assets and liabilities:          
Accounts receivable   7,070    893 
Inventories   6,767    1,118 
Prepaid expenses and other assets   21,821    11,326 
Accounts payable   (769)   5,321 
Other current liabilities and income taxes   (15,442)   (18,101)
Deferred revenue and returns liability   6,678    (1,228)
Other non-current liabilities   970    (3,222)
Net cash provided by operating activities   100,503    71,354 
           
Investing Activities          
Purchases of available-for-sale investments   (199,347)   (184,170)
Sales and maturities of available-for-sale investments   255,112    151,428 
Purchases of property and equipment   (10,394)   (9,402)
Purchases of other assets   (820)   (2,588)
Acquisition of business, net of cash acquired   (316,809)   -- 
Net cash used in investing activities   (272,258)   (44,732)
           
Financing Activities          
Proceeds from issuance of debt   845,000    -- 
Payments on debt   (597,446)   -- 
Repurchases of common stock   (16,287)   (26,716)
Payment of taxes withheld for vested stock awards   (16,756)   (14,509)
Proceeds from the issuance of common stock   7,757    7,109 
Net cash provided by (used in) financing activities   222,268    (34,116)
           
Increase (decrease) in cash and cash equivalents   50,513    (7,494)
Cash and cash equivalents at beginning of period   227,146    197,043 
Cash and cash equivalents at end of period  $277,659   $189,549